ロード中...
Mechanisms of Primary and Secondary Resistance to Immune Checkpoint Inhibitors in Cancer
Immune checkpoint inhibitors (ICPis) have revolutionized cancer therapy with broad activities against a wide range of malignancies. However, in many malignancies their efficacy remains limited due to the primary resistance. Furthermore, a high percentage of patients develop progression due to the se...
保存先:
| 出版年: | Med Sci (Basel) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6410194/ https://ncbi.nlm.nih.gov/pubmed/30678257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medsci7020014 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|